Cargando…

Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy

The COVID-19 pandemic has accelerated the development of nucleoside analogs to treat respiratory virus infections, with remdesivir being the first compound to receive worldwide authorization and three other nucleoside analogs (i.e. favipiravir, molnupiravir, and bemnifosbuvir) in the pipeline. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stevaert, Annelies, Groaz, Elisabetta, Naesens, Lieve
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671222/ https://www.ncbi.nlm.nih.gov/pubmed/36403338 http://dx.doi.org/10.1016/j.coviro.2022.101279

Ejemplares similares

The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design
por: Stevaert, Annelies, et al.
Publicado: (2016)

Overview of Biologically Active Nucleoside Phosphonates
por: Groaz, Elisabetta, et al.
Publicado: (2021)

Reprogramming of the Antibacterial Drug Vancomycin Results in Potent Antiviral Agents Devoid of Antibacterial Activity
por: Szűcs, Zsolt, et al.
Publicado: (2020)

N-acylhydrazone inhibitors of influenza virus PA endonuclease with versatile metal binding modes
por: Carcelli, Mauro, et al.
Publicado: (2016)

Airway proteases: an emerging drug target for influenza and other respiratory virus infections
por: Laporte, Manon, et al.
Publicado: (2017)

Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results
por: Oey, Abbie, et al.
Publicado: (2023)

Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease
por: Stevaert, Annelies, et al.
Publicado: (2022)

Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents
por: Szűcs, Zsolt, et al.
Publicado: (2018)

Antiviral nucleoside analogs
por: Kataev, Vladimir E., et al.
Publicado: (2021)

Nucleosides for the treatment of respiratory RNA virus infections
por: Jordan, Paul C, et al.
Publicado: (2018)

Nucleoside Analogs with Fleximer Nucleobase
por: Chudinov, Mikhail V.
Publicado: (2020)

The nucleoside analog clitocine is a potent and efficacious readthrough agent
por: Friesen, Westley J., et al.
Publicado: (2017)

Genotypic resistance profiles in Chinese patients with chronic hepatitis B virus infection and the efficacy of nucleoside analog rescue therapy
por: Liang, Ling-Bo, et al.
Publicado: (2015)

O-2-Alkylated Cytosine Acyclic Nucleoside Phosphonamidate Prodrugs Display Pan-Genotype Antiviral Activity against African Swine Fever Virus
por: Goulding, Leah V., et al.
Publicado: (2022)

Sapacitabine, the prodrug of CNDAC, is a nucleoside analog with a unique action mechanism of inducing DNA strand breaks
por: Liu, Xiao-Jun, et al.
Publicado: (2012)

Repurposing Nucleoside Analogs for Human Coronaviruses
por: Zandi, Keivan, et al.
Publicado: (2020)

Nucleoside analogs NM107 and AT-527 are antiviral against rubella virus
por: Dittmar, Mark, et al.
Publicado: (2023)

Novel Polymyxin-Inspired Peptidomimetics Targeting the SARS-CoV-2 Spike:hACE2 Interface
por: Bugatti, Kelly, et al.
Publicado: (2023)

New insights into the synergism of nucleoside analogs with radiotherapy
por: Lee, Michael W, et al.
Publicado: (2013)

Nucleoside analogs to manage sequence divergence in nucleic acid amplification and SNP detection
por: Yang, Zunyi, et al.
Publicado: (2018)

Synthesis and Biological Evaluation of Novel (thio)semicarbazone-Based Benzimidazoles as Antiviral Agents against Human Respiratory Viruses
por: Francesconi, Valeria, et al.
Publicado: (2020)

Efficacy of different nucleoside analog rescue therapies for entecavir-resistant chronic hepatitis B patients
por: Shang, Jin, et al.
Publicado: (2021)

Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses
por: Borbone, Nicola, et al.
Publicado: (2021)

Antiviral and Antimicrobial Nucleoside Derivatives: Structural Features and Mechanisms of Action
por: Zenchenko, A. A., et al.
Publicado: (2021)

Diverse models for anti-HIV activity of purine nucleoside analogs
por: Khatri, Naveen, et al.
Publicado: (2015)

Entrapment of DNA topoisomerase-DNA complexes by nucleotide/nucleoside analogs
por: Gmeiner, William H.
Publicado: (2019)

Synthesis of Sugar and Nucleoside Analogs and Evaluation of Their Anticancer and Analgesic Potentials
por: Hussain, Fahad, et al.
Publicado: (2022)

Nucleoside Analogs: A Review of Its Source and Separation Processes
por: Wang, Pan, et al.
Publicado: (2023)

HIV-1 Polymerase Inhibition by Nucleoside Analogs: Cellular- and Kinetic Parameters of Efficacy, Susceptibility and Resistance Selection
por: von Kleist, Max, et al.
Publicado: (2012)

Targeted Delivery of Deoxycytidine Kinase to Her2-Positive Cells Enhances the Efficacy of the Nucleoside Analog Fludarabine
por: Koduvayur, Sujatha P., et al.
Publicado: (2016)

Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis
por: Pedersen, Niels C, et al.
Publicado: (2019)

Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice.
por: Schäfer, Alexandra, et al.
Publicado: (2021)

Novel L-nucleoside analog, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia
por: Bankar, Aniket, et al.
Publicado: (2019)

Ritter reaction-mediated syntheses of 2-oxaadamantan-5-amine, a novel amantadine analog
por: Leiva, Rosana, et al.
Publicado: (2015)

The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways
por: Laporte, Manon, et al.
Publicado: (2021)

Structural basis for activation of the therapeutic l-nucleoside analogs 3TC and troxacitabine by human deoxycytidine kinase
por: Sabini, Elisabetta, et al.
Publicado: (2007)

Nucleoside Analogs That Inhibit SARS-CoV-2 Replication by Blocking Interaction of Virus Polymerase with RNA
por: Matyugina, Elena, et al.
Publicado: (2023)

Identification of Structural and Molecular Features Involved in the Transport of 3′-Deoxy-Nucleoside Analogs by Human Equilibrative Nucleoside Transporter 3
por: Rahman, MD Fazlur, et al.
Publicado: (2018)

Evaluation of Nucleoside Analogs as Antimicrobials Targeting Unique Enzymes in Borrelia burgdorferi
por: Chakraborti, Monideep, et al.
Publicado: (2020)

Structural Insights Into Tautomeric Dynamics in Nucleic Acids and in Antiviral Nucleoside Analogs
por: Fedeles, Bogdan I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_noph8d9507qp8isddcsk0cmosf